Teradata (NYSE:TDC – Free Report) had its target price cut by Evercore ISI from $37.00 to $32.00 in a research report report ...

Evercore ISI analyst Kirk Materne maintained a Hold rating on Tyler Technologies (TYL – Research Report) yesterday and set a price target of ...

Evercore ISI has upgraded CRISPR (CRSP) to outperform from in line, citing upcoming data catalysts. Read more here.

Fintel reports that on February 14, 2025, Evercore ISI Group upgraded their outlook for CRISPR Therapeutics (NasdaqGM:CRSP) ...

Evercore ISI analyst David Palmer maintained a Buy rating on Restaurant Brands International (QSR – Research Report) yesterday and set a price ...

Trade Desk (NASDAQ:TTD – Get Free Report) was downgraded by stock analysts at Evercore ISI from an “outperform” rating to an “inline” rating in a research note issued to investors on Thursday, ...

Walgreens Chief Executive Officer Tim Wentworth reiterated on an earnings call last month that the company plans to divest ...

Evercore ISI analysts upgraded CRISPR Therapeutics stock from an In Line to an Outperform rating and increased the price target significantly to $99 from the previous $60. The upgrade comes as ...

Evercore researchers noted ... especially among hyperscalelarge-scale cloud infrastructure providers. The company projects Nvidia to be five to ten years ahead of rivals like Advanced Micro ...

Nvidia (NASDAQ:NVDA) was added to Evercore ISI's Tactical Outperform list on Monday as analysts turned bullish ahead of the company's fiscal fourth-quarter earnings report on February 26.

The health chain is is working with Evercore for assistance as it explores options that include a sale or restructuring of ...